Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout.
DEERFIELD, Ill., and OSAKA, Japan, Nov. 24 /PRNewswire/ -- Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., announced today that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended that the FDA approve febuxostat for the treatment...

Vicenza Hospital Becomes First European Facility to Purchase Its Second CyberKnife System.
New Unit Will Enable Italian Hospital to Expand Radiosurgery to Treat Lung and Prostate Cancer SUNNYVALE, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Accuray Incorporated , a global leader in the field of radiosurgery, announced today that Vicenza Hospital, Ospedale Civile San Bortolo in Italy has become the first...

Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin.
- Company to Explore Strategic Alternatives for Ongoing Preclinical Research Programs - SOUTH SAN FRANCISCO, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on innovative oncology therapies, announced today that it will be exploring strategic alternatives for its preclinical research programs in...

Advanced Medical Institute Reports Results for the Quarter Ended September 30.
HEALTH AND BEAUTY CLOSE-UP-26 November 2008-Advanced Medical Institute Reports Results for the Quarter Ended September 30(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Advanced Medical Institute Inc. (AMI), a provider of treatment for Erectile Dysfunction and Premature Ejaculation in Australia and New Zealand, has announced results for the quarter ended...

EastMed Inc. receives FDA clearance to market uresta(TM) in the U.S.
NORWELL, MA, Nov. 25 /PRNewswire/ -- EastMed Inc., the medical manufacturing company that caters specifically to women's health and wellness, has received FDA clearance to market its flagship product, uresta(TM) Continence Care, in the U.S. "We are delighted to get the official word from the FDA," said...

Teresa J. Sakraida named a Robert Wood Johnson Foundation Nurse Faculty Scholar: new national program seeks to advance careers of talented junior nursing faculty.
AURORA, Colo. (Sept. 10, 2008)--Teresa J. Sakraida, RN, PhD, MS, MSEd, an assistant professor in the University of Colorado Denver College of Nursing, was one of 15 junior faculty nationwide to receive an inaugural Robert Wood Johnson Foundation Nurse Faculty Scholar award. The three-year, $350,000 grant began on September...

Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant.
We report a case of a 49 year-old male who had undergone liver transplant due to hepatitis C, Laennec's cirrhosis, and hepatocellular carcinoma, and was treated with etanercept for recalcitrant generalized psoriasis. Clearance of psoriasis was achieved without any adverse effects or complications of his current conditions....

ROCKWELL MEDICAL ANNOUNCES UPDATED DSMB RESULTS.
Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), Wixom, Mich., a specialty pharma company focused on drug and device development in the renal market, has reported that the independent Data Safety Monitoring Board (DSMB) providing oversight for the SFP Phase II-b iron maintenance therapy dose-range study reviewed the cumulative safety data from...

OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study.
First-line trial currently shows median overall survival of 27.5 months for OGX-011 in combination with docetaxel and prednisone and a 16.9 months overall survival for docetaxel and prednisone alone. Achievement of survival benefit milestone results in release of all remaining escrowed shares of OGXI. BOTHELL,...

Nurse sensitive indicators: a staff nurse perspective.
As of October, 2008, the Centers for Medicare and Medicaid Services (CMS) will discontinue reimbursing for eight hospital acquired conditions. Four of these, pressure ulcers, patient falls, catheter associated urinary tract infections, and vascular catheter associated infections, are also identified as "nurse sensitive" by the National Quality Forum (NQF)...